Back to search

Prognostic Value of Urokinase Plasminogen Activator and Plasminogen Activator Inhibitor-1 in Renal Cell Cancer

Data up to Jan 2025

Published1996
Citations37
References23

Total Citations Per Year

Abstract

References (23)

Plasminogen Activators, Tissue Degradation, and Cancer

1985 • 2,584 citations

A Detergent‐trypsin method for the preparation of nuclei for flow cytometric DNA analysis

1983 • 1,681 citations

E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells.

1991 • 1,592 citations

Receptor-mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1.

1990 • 374 citations

Testing a Sequence of Observations for a Shift in Location

1977 • 314 citations

Clinical Relevance of the Urokinase-Type and Tissue-Type Plasminogen Activators and of Their Type 1 Inhibitor in Breast Cancer

1991 • 236 citations

Accessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitor.

1989 • 182 citations

Stratification of risk factors in renal cell carcinoma

1983 • 157 citations

Age dependence of ischaemic heart syndromes and the contribution of haemostatic deviations

1992 • 146 citations

Stratification of risk factors in renal cell carcinoma

1983 • 144 citations

Role of the urokinase receptor in facilitating extracellular matrix invasion by cultured colon cancer.

1991 • 123 citations

Renal Adenocarcinoma in Young Adults: Survival and Variables Affecting Prognosis

1981 • 117 citations

Recombinant soluble urokinase receptor as a scavenger for urokinase‐type plasminogen activator (uPA)

1994 • 101 citations

Prognostic Parameters in Renal Cell Carcinoma - a New Approach(1)

1989 • 86 citations

Plasminogen activator activity in bone metastases of prostatic carcinomas as compared to primary tumors.

1985 • 67 citations

Expression of Urokinase and Its Receptor in Invasive and Non-Invasive Prostate Cancer Cell Lines

1992 • 55 citations

Tumour-associated fibrinolysis: the prognostic relevance of plasminogen activators uPA and tPA in human breast cancer.

1990 • 51 citations

Comparative study of plasminogen activators in cancers and normal mucosae of human urinary bladder.

1989 • 49 citations

Age-related changes in the basal level of tissue-type plasminogen activator and plasminogen activator inhibitor 1

1992 • 13 citations

Prognostic Value of Urokinase Plasminogen Activator for Prostatic Carcinoma

1994 • 5 citations

Fibrinolysis and atherosclerosis

1990 • 4 citations

Platelet mediated inflammation and thrombosis in thrombocythemia

1990 • 4 citations

Protease and Plasminogen Activator Activity in Human Bladder Carcinoma

1990 • 3 citations

Cited By (0)

Loading...
Prognostic Value of Urokinase Plasminogen Activator and Plasminogen Activator Inhibitor-1… (1996) – The Journal of Urology | Metascience Observatory Explorer